application of Vasadi-Dashanga tablet in hyperacidity

Role of Vasadi-Dashanga Vati in amlapitta - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074093

Enrollment

Registered

2024-09-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patient presenting with sign and symptoms of Amlapitta. 2. Age above 20 years and below 60 years. 3. Chronicity up to 5 years.

Exclusion criteria

Exclusion criteria: 1. Patients below 20 years and 60 above years. 2. Chronicity more than 5 years. 3. Known case of - Gastric ulcer, Duodenal ulcer, Hiatus Hernia, Asthma, Tuberculosis, Malignancies, Liver Cirrhosis and Chronic Renal Failure etc. exclude from the study. • Any other Major illness.

Design outcomes

Primary

Measure	Time frame
improvement in 1Avipaka – Indigestion 2Klama- Fatigue 3Utklesha – Nausea 4Tikta-amla-udagara - Acid eructation 5Gaurav - Heaviness in whole body 6Hrita-kantha-daha - Burning in chest and throat 7Aruchi – Anorexia Timepoint: 4 weeks	—

Secondary

Measure	Time frame
improvement in digestion related problems & complications of amlapittaTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Dipti Bisht

Rishikul Campus, Uttarakhand Ayurved University, Haridwar

dr.opsingh63@gmail.com9411503035

Outcome results